Maxcyte Stock Price History
MXCT Stock | USD 3.52 0.14 4.14% |
If you're considering investing in MaxCyte Stock, it is important to understand the factors that can impact its price. As of today, the current price of MaxCyte stands at 3.52, as last reported on the 28th of November, with the highest price reaching 3.58 and the lowest price hitting 3.38 during the day. MaxCyte has Sharpe Ratio of -0.0793, which conveys that the firm had a -0.0793% return per unit of risk over the last 3 months. MaxCyte exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MaxCyte's Risk Adjusted Performance of (0.05), mean deviation of 2.47, and Standard Deviation of 3.29 to check out the risk estimate we provide.
At this time, MaxCyte's Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 281.7 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 222.4 M in 2024. . At this time, MaxCyte's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.20 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.13). MaxCyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
MaxCyte |
Sharpe Ratio = -0.0793
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | MXCT |
Estimated Market Risk
3.33 actual daily | 29 71% of assets are more volatile |
Expected Return
-0.26 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MaxCyte is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MaxCyte by adding MaxCyte to a well-diversified portfolio.
Price Book 1.7407 | Enterprise Value Ebitda (11.07) | Price Sales 8.1427 | Shares Float 96.5 M | Wall Street Target Price 9.25 |
MaxCyte Stock Price History Chart
There are several ways to analyze MaxCyte Stock price data. The simplest method is using a basic MaxCyte candlestick price chart, which shows MaxCyte price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 19, 2024 | 4.35 |
Lowest Price | November 18, 2024 | 3.23 |
MaxCyte November 28, 2024 Stock Price Synopsis
Various analyses of MaxCyte's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell MaxCyte Stock. It can be used to describe the percentage change in the price of MaxCyte from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of MaxCyte Stock.MaxCyte Price Rate Of Daily Change | 1.04 | |
MaxCyte Price Action Indicator | 0.11 | |
MaxCyte Price Daily Balance Of Power | 0.70 |
MaxCyte November 28, 2024 Stock Price Analysis
MaxCyte Stock Price History Data
The price series of MaxCyte for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 1.12 with a coefficient of variation of 6.64. The daily prices for the period are spread out with arithmetic mean of 3.78. The median price for the last 90 days is 3.79.Open | High | Low | Close | Volume | ||
11/28/2024 | 3.38 | 3.58 | 3.38 | 3.52 | ||
11/27/2024 | 3.38 | 3.58 | 3.38 | 3.52 | 776,537 | |
11/26/2024 | 3.60 | 3.61 | 3.33 | 3.38 | 966,975 | |
11/25/2024 | 3.58 | 3.75 | 3.52 | 3.61 | 2,919,618 | |
11/22/2024 | 3.45 | 3.63 | 3.39 | 3.55 | 516,969 | |
11/21/2024 | 3.48 | 3.51 | 3.36 | 3.45 | 651,511 | |
11/20/2024 | 3.33 | 3.50 | 3.30 | 3.49 | 447,641 | |
11/19/2024 | 3.24 | 3.36 | 3.17 | 3.33 | 579,078 | |
11/18/2024 | 3.44 | 3.45 | 3.22 | 3.23 | 675,345 | |
11/15/2024 | 3.47 | 3.53 | 3.36 | 3.42 | 890,406 | |
11/14/2024 | 3.55 | 3.61 | 3.41 | 3.44 | 969,010 | |
11/13/2024 | 3.56 | 3.60 | 3.40 | 3.55 | 662,918 | |
11/12/2024 | 3.51 | 3.64 | 3.43 | 3.54 | 796,659 | |
11/11/2024 | 3.39 | 3.60 | 3.23 | 3.58 | 654,050 | |
11/08/2024 | 3.45 | 3.64 | 3.37 | 3.39 | 481,987 | |
11/07/2024 | 4.01 | 4.01 | 3.34 | 3.46 | 2,362,652 | |
11/06/2024 | 4.00 | 4.15 | 3.80 | 3.88 | 876,927 | |
11/05/2024 | 3.73 | 3.87 | 3.70 | 3.86 | 314,140 | |
11/04/2024 | 3.73 | 3.82 | 3.66 | 3.76 | 319,624 | |
11/01/2024 | 3.65 | 3.78 | 3.61 | 3.77 | 367,093 | |
10/31/2024 | 3.52 | 3.67 | 3.52 | 3.58 | 185,308 | |
10/30/2024 | 3.54 | 3.63 | 3.52 | 3.54 | 279,465 | |
10/29/2024 | 3.65 | 3.65 | 3.50 | 3.57 | 187,568 | |
10/28/2024 | 3.60 | 3.74 | 3.59 | 3.61 | 324,789 | |
10/25/2024 | 3.83 | 3.83 | 3.56 | 3.57 | 336,337 | |
10/24/2024 | 3.87 | 3.87 | 3.77 | 3.80 | 278,996 | |
10/23/2024 | 3.81 | 3.87 | 3.74 | 3.82 | 307,019 | |
10/22/2024 | 3.74 | 3.88 | 3.64 | 3.84 | 240,205 | |
10/21/2024 | 3.77 | 3.90 | 3.72 | 3.76 | 284,084 | |
10/18/2024 | 3.79 | 3.81 | 3.75 | 3.77 | 209,312 | |
10/17/2024 | 3.87 | 3.87 | 3.74 | 3.79 | 177,463 | |
10/16/2024 | 3.83 | 3.90 | 3.79 | 3.85 | 184,616 | |
10/15/2024 | 3.87 | 3.87 | 3.73 | 3.78 | 178,392 | |
10/14/2024 | 3.87 | 3.93 | 3.83 | 3.87 | 220,104 | |
10/11/2024 | 3.76 | 3.88 | 3.67 | 3.88 | 302,761 | |
10/10/2024 | 3.66 | 3.90 | 3.63 | 3.70 | 413,427 | |
10/09/2024 | 3.88 | 3.91 | 3.66 | 3.67 | 292,131 | |
10/08/2024 | 3.79 | 3.89 | 3.75 | 3.88 | 406,062 | |
10/07/2024 | 3.67 | 3.80 | 3.63 | 3.78 | 391,172 | |
10/04/2024 | 3.70 | 3.74 | 3.59 | 3.67 | 252,597 | |
10/03/2024 | 3.79 | 3.79 | 3.61 | 3.62 | 221,184 | |
10/02/2024 | 3.75 | 3.79 | 3.62 | 3.74 | 410,829 | |
10/01/2024 | 3.89 | 3.89 | 3.69 | 3.70 | 340,661 | |
09/30/2024 | 3.85 | 3.98 | 3.79 | 3.89 | 413,194 | |
09/27/2024 | 3.97 | 3.98 | 3.85 | 3.87 | 396,028 | |
09/26/2024 | 3.88 | 3.94 | 3.80 | 3.89 | 337,909 | |
09/25/2024 | 3.89 | 3.94 | 3.78 | 3.81 | 243,488 | |
09/24/2024 | 3.97 | 3.99 | 3.88 | 3.90 | 179,180 | |
09/23/2024 | 4.13 | 4.20 | 3.94 | 3.96 | 357,831 | |
09/20/2024 | 4.29 | 4.29 | 4.04 | 4.10 | 794,251 | |
09/19/2024 | 4.21 | 4.41 | 4.12 | 4.35 | 432,221 | |
09/18/2024 | 4.07 | 4.25 | 3.99 | 4.06 | 277,370 | |
09/17/2024 | 4.16 | 4.24 | 4.01 | 4.10 | 321,929 | |
09/16/2024 | 4.08 | 4.26 | 3.99 | 4.12 | 331,297 | |
09/13/2024 | 4.00 | 4.15 | 3.99 | 4.03 | 239,011 | |
09/12/2024 | 3.94 | 4.07 | 3.82 | 4.00 | 252,296 | |
09/11/2024 | 3.94 | 3.98 | 3.80 | 3.91 | 291,202 | |
09/10/2024 | 3.98 | 3.99 | 3.76 | 3.96 | 371,012 | |
09/09/2024 | 3.82 | 3.86 | 3.72 | 3.83 | 352,096 | |
09/06/2024 | 3.96 | 3.97 | 3.73 | 3.79 | 317,938 | |
09/05/2024 | 3.92 | 4.13 | 3.87 | 3.96 | 181,145 |
About MaxCyte Stock history
MaxCyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MaxCyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MaxCyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MaxCyte stock prices may prove useful in developing a viable investing in MaxCyte
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 103.3 M | 66.8 M | |
Net Loss | -21.2 M | -22.3 M |
MaxCyte Quarterly Net Working Capital |
|
MaxCyte Stock Technical Analysis
MaxCyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
All Next | Launch Module |
MaxCyte Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for MaxCyte's price direction in advance. Along with the technical and fundamental analysis of MaxCyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MaxCyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.40) | |||
Total Risk Alpha | (0.73) | |||
Treynor Ratio | (0.17) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for MaxCyte Stock Analysis
When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.